| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $164.50B | +21.9% |
| Cost of Revenue | $30.16B | +16.2% |
| R&D Expense | $43.87B | +14.0% |
| SG&A Expense | $9.74B | -14.6% |
| Operating Income | $69.38B | +48.4% |
| Interest Expense | $683.0M | +53.1% |
| Pre-tax Income | $70.66B | +49.0% |
| Income Tax | $8.30B | -0.3% |
| Net Income | $62.36B |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $43.89B | +4.8% |
| Short-term Investments | $33.93B | +44.1% |
| Accounts Receivable | $16.99B | +5.1% |
| Current Assets | $100.05B | +17.2% |
| Total Assets | $276.05B | +20.2% |
| Current Liabilities | $33.60B | +5.1% |
| Long-term Debt | $28.83B | +56.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $91.33B | +28.4% |
| Capital Expenditures | $37.26B | +36.6% |
| Investing Cash Flow | -$47.15B | -92.5% |
| Financing Cash Flow | -$40.78B | -109.1% |
| Free Cash Flow | $54.07B | +23.3% |
| +59.5% |
| EPS (Basic) | $24.61 | +62.0% |
| EPS (Diluted) | $23.86 | +60.5% |
| Total Liabilities |
| $93.42B |
| +22.2% |
| Stockholders' Equity | $182.64B | +19.2% |